BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 8923879)

  • 1. Leukemia inhibitory factor (LIF) induces acute adrenocorticotrophic hormone (ACTH) secretion in fetal rhesus macaque primates: a novel dynamic test of pituitary function.
    Akita S; Conn PM; Melmed S
    J Clin Endocrinol Metab; 1996 Nov; 81(11):4170-8. PubMed ID: 8923879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytokine-dependent gp130 receptor subunit regulates human fetal pituitary adrenocorticotropin hormone and growth hormone secretion.
    Shimon I; Yan X; Ray DW; Melmed S
    J Clin Invest; 1997 Jul; 100(2):357-63. PubMed ID: 9218512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leukemia inhibitory factor (LIF) stimulates proopiomelanocortin (POMC) expression in a corticotroph cell line. Role of STAT pathway.
    Ray DW; Ren SG; Melmed S
    J Clin Invest; 1996 Apr; 97(8):1852-9. PubMed ID: 8621768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pituitary corticotroph SOCS-3: novel intracellular regulation of leukemia-inhibitory factor-mediated proopiomelanocortin gene expression and adrenocorticotropin secretion.
    Auernhammer CJ; Chesnokova V; Bousquet C; Melmed S
    Mol Endocrinol; 1998 Jul; 12(7):954-61. PubMed ID: 9658400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human and murine pituitary expression of leukemia inhibitory factor. Novel intrapituitary regulation of adrenocorticotropin hormone synthesis and secretion.
    Akita S; Webster J; Ren SG; Takino H; Said J; Zand O; Melmed S
    J Clin Invest; 1995 Mar; 95(3):1288-98. PubMed ID: 7883977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leukemia inhibitory factor as an intrapituitary mediator of ACTH secretion.
    Schwartz J; Ray DW; Perez FM
    Neuroendocrinology; 1999 Jan; 69(1):34-43. PubMed ID: 9892849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leukemia inhibitory factor induces differentiation of pituitary corticotroph function: an immuno-neuroendocrine phenotypic switch.
    Stefana B; Ray DW; Melmed S
    Proc Natl Acad Sci U S A; 1996 Oct; 93(22):12502-6. PubMed ID: 8901611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leukemia inhibitory factor modulates interleukin-1beta-induced activation of the hypothalamo-pituitary-adrenal axis.
    Auernhammer CJ; Chesnokova V; Melmed S
    Endocrinology; 1998 May; 139(5):2201-8. PubMed ID: 9564823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leukemia inhibitory factor regulates proopiomelanocortin transcription.
    Ray DW; Ren SG; Melmed S
    Ann N Y Acad Sci; 1998 May; 840():162-73. PubMed ID: 9629248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opposing effects of pituitary leukemia inhibitory factor and SOCS-3 on the ACTH axis response to inflammation.
    Chesnokova V; Kariagina A; Melmed S
    Am J Physiol Endocrinol Metab; 2002 May; 282(5):E1110-8. PubMed ID: 11934677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct regulation of pituitary proopiomelanocortin by STAT3 provides a novel mechanism for immuno-neuroendocrine interfacing.
    Bousquet C; Zatelli MC; Melmed S
    J Clin Invest; 2000 Dec; 106(11):1417-25. PubMed ID: 11104795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of stimulated and spontaneous adrenocorticotropin secretory dynamics identifies distinct components of cortisol feedback inhibition in healthy humans.
    Dorin RI; Ferries LM; Roberts B; Qualls CR; Veldhuis JD; Lisansky EJ
    J Clin Endocrinol Metab; 1996 Nov; 81(11):3883-91. PubMed ID: 8923833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. cAMP neuropeptide agonists induce pituitary suppressor of cytokine signaling-3: novel negative feedback mechanism for corticotroph cytokine action.
    Bousquet C; Chesnokova V; Kariagina A; Ferrand A; Melmed S
    Mol Endocrinol; 2001 Nov; 15(11):1880-90. PubMed ID: 11682619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Murine leukemia inhibitory factor gene disruption attenuates the hypothalamo-pituitary-adrenal axis stress response.
    Chesnokova V; Auernhammer CJ; Melmed S
    Endocrinology; 1998 May; 139(5):2209-16. PubMed ID: 9564824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A common pro-opiomelanocortin-binding element mediates leukemia inhibitory factor and corticotropin-releasing hormone transcriptional synergy.
    Bousquet C; Ray DW; Melmed S
    J Biol Chem; 1997 Apr; 272(16):10551-7. PubMed ID: 9099700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leukemia inhibitory factor mediates the hypothalamic pituitary adrenal axis response to inflammation.
    Chesnokova V; Melmed S
    Endocrinology; 2000 Nov; 141(11):4032-40. PubMed ID: 11089533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypothalamic-pituitary cytokine network.
    Kariagina A; Romanenko D; Ren SG; Chesnokova V
    Endocrinology; 2004 Jan; 145(1):104-12. PubMed ID: 14512435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leukemia inhibitory factor (LIF) modulates pro-opiomelanocortin (POMC) gene regulation in stably transfected AtT-20 cells overexpressing LIF.
    Li QL; Yano H; Ren SG; Li X; Friedman TC; Melmed S
    Endocrine; 1997 Dec; 7(3):325-30. PubMed ID: 9657069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disrupted murine leukemia inhibitory factor (LIF) gene attenuates adrenocorticotropic hormone (ACTH) secretion.
    Akita S; Malkin J; Melmed S
    Endocrinology; 1996 Jul; 137(7):3140-3. PubMed ID: 8770940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-11 stimulates proopiomelanocortin gene expression and adrenocorticotropin secretion in corticotroph cells: evidence for a redundant cytokine network in the hypothalamo-pituitary-adrenal axis.
    Auernhammer CJ; Melmed S
    Endocrinology; 1999 Apr; 140(4):1559-66. PubMed ID: 10098488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.